Basel Medical (BMGL) Long-Term Deferred Tax (2024 - 2025)
Basel Medical recorded quarterly Long-Term Deferred Tax of $36779.8 in Q2 2025, down 34.75% quarter-over-quarter from $56364.0 in Q4 2024, and down 35.38% year-over-year from $56916.5 in Q2 2024.
Basel Medical's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $36779.8 for Q2 2025.
- In Q2 2025, Long-Term Deferred Tax fell 35.38% year-over-year to $36779.8; the TTM figure through Jun 2025 stood at $36779.8 (down 35.38% YoY), while the FY2025 annual figure was $37640.0, down 33.87% from the prior year.
- Long-Term Deferred Tax came in at $36779.8 for Q2 2025 at Basel Medical, down from $56364.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $56916.5 in Q2 2024 to a low of $36779.8 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | Basel Medical | 8.57 Mn | 6.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 36,779.79 |
| Dec 31, 2024 | 56,364.00 |
| Jun 30, 2024 | 56,916.48 |